Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
02 Jun, 2026, 05.48 AM IST
If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil KhorakiwalaWockhardt Hospitals is set to launch its antibiotic Zaynich in the US. Zahabiya Khorakiwala will lead US operations. The drug is expected t...
02 Jun, 2026, 12.01 AM IST
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
01 Jun, 2026, 10.11 AM IST
FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
01 Jun, 2026, 07.44 AM IST
Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
30 May, 2026, 11.17 PM IST
Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
29 May, 2026, 11.05 AM IST
Wockhardt gets CDSCO nod for Zaynich antibioticWockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...
28 May, 2026, 11.52 AM IST
Wockhardt shares bounce back 4% after two-day slumpWockhardt shares on December 1 jumped 19% after the US FDA accepted the company’s New Drug Application for Zaynich, its first-in-class anti...
05 Dec, 2025, 12.04 PM IST
USFDA accepts Wockhardt’s NDA for breakthrough antibiotic ZaynichThis is the first time ever that an NDA from a new chemical entity (NCE) from an Indian pharma company has been filed and accepted by the U...
01 Dec, 2025, 07.47 PM IST
Wockhardt shares zoom 20% after USFDA’s historic approval for antibiotic drug ZaynichThe US FDA has accepted Wockhardt’s New Drug Application for Zaynich, its first-in-class antibiotic. This marks the first-ever acceptance o...
01 Dec, 2025, 04.28 PM IST
Wockhardt gets NDA status for novel antibiotic ZaynichWockhardt, an emerging powerhouse in the Indian pharmaceutical arena, has just scored a game-changing triumph! The US health regulator has ...
01 Dec, 2025, 02.40 PM IST
Wockhardt activates Zaynich push, eyes global licensing dealsWockhardt is advancing Zaynich, a novel antibiotic combination, targeting drug-resistant infections, with plans for regulatory submissions ...
01 Jul, 2025, 05.11 AM IST
Wockhardt eyes USD 7 billion market opportunity for antibiotic Zaynich in US, EuropeWockhardt's new antibiotic, Zaynich, targeting gram-negative infections, anticipates a significant USD 7 billion market in the US and Europ...
05 Jun, 2025, 05.28 PM IST
Wockhardt shares rise 10% after Zaynich aids successful liver transplant trialWockhardt's shares surged 8.6% after its antibiotic Zaynich successfully treated a US cancer patient, enabling a liver transplant and chemo...
16 Dec, 2024, 10.44 AM IST
Can Zaynich do for Wockhardt what Ozempic did for Novo Nordisk?Wockhardt's Zaynich antibiotic surged stock by 75%. CEO Habil Khorakiwala cited its uniqueness; phase three trials end this fiscal year. Co...
06 Jul, 2024, 11.12 AM IST
Wockhardt shares skyrocket 18% to fresh 52-week high. Here’s why?Shares of Wockhardt surged 18% in early trading to reach a new 52-week high of Rs 811.50 on NSE. The sharp increase followed the company's ...
01 Jul, 2024, 12.11 PM IST
Wockhardt aims to launch antibiotic with USD 25 bn mkt potential by early FY26With strong financial backing and successful research, Wockhardt is poised for the launch of Zaynich, an antibiotic targeting high resistan...
28 Jun, 2024, 05.02 PM IST